Is PureTech Health Stock a Good Investment?
PureTech Health Investment Advice | PRTC |
- Examine PureTech Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research PureTech Health's leadership team and their track record. Good management can help PureTech Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact PureTech Health's business and its evolving consumer preferences.
- Compare PureTech Health's performance and market position to its competitors. Analyze how PureTech Health is positioned in terms of product offerings, innovation, and market share.
- Check if PureTech Health pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about PureTech Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in PureTech Health PLC stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if PureTech Health PLC is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine PureTech Health Stock
Researching PureTech Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company has price-to-book ratio of 1.27. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PureTech Health PLC recorded a loss per share of 3.0. The entity had not issued any dividends in recent years.
To determine if PureTech Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding PureTech Health's research are outlined below:
| PureTech Health PLC generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 3.33 M. Net Loss for the year was (65.7 M) with loss before overhead, payroll, taxes, and interest of (81.55 M). | |
| PureTech Health PLC currently holds about 368.03 M in cash with (105.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.84. | |
| PureTech Health PLC has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: PureTech Health stock hits 52-week low at 16.71 amid market challenges - Investing.com UK |
PureTech Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in PureTech Health PLC. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to PureTech Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact PureTech Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises PureTech Health's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-04-28 | 2023-03-31 | -1.76 | -0.08 | 1.68 | 95 | ||
2022-04-26 | 2022-03-31 | -2.55 | 0.05 | 2.6 | 101 | ||
2022-08-25 | 2022-06-30 | -2.78 | -0.1 | 2.68 | 96 |
PureTech Health Target Price Consensus
PureTech target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. PureTech Health's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 2 | Strong Buy |
Most PureTech analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand PureTech stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of PureTech Health PLC, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationPureTech Health Target Price Projection
PureTech Health's current and average target prices are 16.82 and 53.25, respectively. The current price of PureTech Health is the price at which PureTech Health PLC is currently trading. On the other hand, PureTech Health's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
PureTech Health Market Quote on 24th of March 2025
Target Price
Analyst Consensus On PureTech Health Target Price
PureTech Health Analyst Ratings
PureTech Health's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about PureTech Health stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of PureTech Health's financials, market performance, and future outlook by experienced professionals. PureTech Health's historical ratings below, therefore, can serve as a valuable tool for investors.Know PureTech Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as PureTech Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PureTech Health PLC backward and forwards among themselves. PureTech Health's institutional investor refers to the entity that pools money to purchase PureTech Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Birch Hill Investment Advisors Llc | 2024-12-31 | 302 K | Millennium Management Llc | 2024-12-31 | 45.3 K | Pentwater Capital Management Lp | 2024-12-31 | 24.1 K | Ubs Group Ag | 2024-12-31 | 1.9 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 100.0 | Adar1 Capital Management Llc | 2024-12-31 | 0.0 | Tower Research Capital Llc | 2024-09-30 | 0.0 |
PureTech Health's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 410.54 M.Market Cap |
|
PureTech Health's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.09) | (0.09) | |
| Return On Capital Employed | (0.26) | (0.25) | |
| Return On Assets | (0.09) | (0.09) | |
| Return On Equity | (0.16) | (0.15) |
Determining PureTech Health's profitability involves analyzing its financial statements and using various financial metrics to determine if PureTech Health is a good buy. For example, gross profit margin measures PureTech Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of PureTech Health's profitability and make more informed investment decisions.
Please note, the presentation of PureTech Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, PureTech Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of PureTech Health's management manipulating its earnings.
Evaluate PureTech Health's management efficiency
PureTech Health PLC has return on total asset (ROA) of (0.1339) % which means that it has lost $0.1339 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2207) %, meaning that it created substantial loss on money invested by shareholders. PureTech Health's management efficiency ratios could be used to measure how well PureTech Health manages its routine affairs as well as how well it operates its assets and liabilities. As of March 24, 2025, Return On Tangible Assets is expected to decline to -0.09. The current year's Return On Capital Employed is expected to grow to -0.25. The current year's Debt To Assets is expected to grow to 0.07, whereas Total Assets are forecasted to decline to about 544.9 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 14.93 | 15.67 | |
| Tangible Book Value Per Share | 14.90 | 15.64 | |
| Enterprise Value Over EBITDA | (47.44) | (49.81) | |
| Price Book Value Ratio | 0.15 | 0.16 | |
| Enterprise Value Multiple | 6.80 | 7.14 | |
| Price Fair Value | 0.15 | 0.16 | |
| Enterprise Value | 551.6 M | 524 M |
Understanding the operational decisions made by PureTech Health management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Beta 0.979 |
Basic technical analysis of PureTech Stock
As of the 24th of March, PureTech Health holds the Risk Adjusted Performance of (0.07), variance of 7.99, and Coefficient Of Variation of (1,092). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PureTech Health, as well as the relationship between them.PureTech Health's Outstanding Corporate Bonds
PureTech Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. PureTech Health PLC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PureTech bonds can be classified according to their maturity, which is the date when PureTech Health PLC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand PureTech Health's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing PureTech Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 1.29 | |||
| Mean Deviation | 2.0 | |||
| Coefficient Of Variation | (1,092) | |||
| Standard Deviation | 2.83 | |||
| Variance | 7.99 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (0.05) | |||
| Treynor Ratio | 1.28 | |||
| Maximum Drawdown | 15.36 | |||
| Value At Risk | (5.77) | |||
| Potential Upside | 3.79 | |||
| Skewness | 0.321 | |||
| Kurtosis | 1.46 |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 1.29 | |||
| Mean Deviation | 2.0 | |||
| Coefficient Of Variation | (1,092) | |||
| Standard Deviation | 2.83 | |||
| Variance | 7.99 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (0.05) | |||
| Treynor Ratio | 1.28 | |||
| Maximum Drawdown | 15.36 | |||
| Value At Risk | (5.77) | |||
| Potential Upside | 3.79 | |||
| Skewness | 0.321 | |||
| Kurtosis | 1.46 |
Consider PureTech Health's intraday indicators
PureTech Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of PureTech Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 16.82 | |||
| Day Typical Price | 16.82 | |||
| Price Action Indicator | 0.055 | |||
| Period Momentum Indicator | 0.11 |
PureTech Health Corporate Filings
| 12th of February 2025 Other Reports | ViewVerify | |
6K | 16th of December 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
13A | 12th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
13A | 7th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
PureTech Stock media impact
Far too much social signal, news, headlines, and media speculation about PureTech Health that are available to investors today. That information is available publicly through PureTech media outlets and privately through word of mouth or via PureTech internal channels. However, regardless of the origin, that massive amount of PureTech data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of PureTech Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of PureTech Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to PureTech Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive PureTech Health alpha.
PureTech Health Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards PureTech Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
PureTech Health Corporate Management
| Anita JD | Senior Property | Profile | |
| Lauren MBA | Chief Officer | Profile | |
| David Elmaleh | CoFounder Advisor | Profile | |
| Spencer Ball | Senior Resources | Profile | |
| III JD | General Secretary | Profile | |
| Joseph Bolen | Chief Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PureTech Health. If investors know PureTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PureTech Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.615 | Earnings Share (3.00) | Revenue Per Share | Quarterly Revenue Growth (0.91) | Return On Assets |
The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between PureTech Health's value and its price, as these two are different measures arrived at by various means. Investors typically determine if PureTech Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PureTech Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.